
Hyperion Biosystems
Designing Diagnostics for the Future.
United States · $29.3M raised
- Employees
- 11–50
- Business Model
- B2B
- Website
- hyperionbiosystems.com
- Total Funding
- $29.3M
- Last Round
- $29.3M Series BJan 2014
- Rounds
- 2
About
Diagnostic devices using AI, computer vision, and physics-based algorithms for lab-grade performance from low-cost hardware.
Summary
Hyperion Biosystems is a Biotech company based in United States. It has raised $29.3M in total across 2 rounds, most recently a $29.3M Series B round in Jan 2014. Investors include Moore Capital and The Engine.
Tech & App Stack
1 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jan 2014
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...

Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.

Specialty pharmaceutical company
Biopharmaceutical services company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...